CLPT
ClearPoint Neuro, Inc. Common Stock
stockNASDAQ
we are a medical device company that develops and commercializes innovative platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or mri, guidance. since our inception in 1998, we have focused on research and product development in the field of interventional mri. from 1998 to 2002, we deployed significant resources to fund our efforts to develop the foundational capabilities for enabling mri-guided interventions and to build an intellectual property position. in 2003, our focus shifted to identifying and building out commercial applications for the technologies we developed in prior years. we have two product platforms. our clearpoint® system, which is in commercial use in the united states, is used to perform minimally invasive surgical procedures in the brain. our cleartrace system, which is still in development, will be used to perform minimally invasive surgical procedures in the heart. bot
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 15.31 | 2026-09-28 | -28.74% | 4.816 |
| 1M | 13.96 | 2026-09-04 | -21.85% | 1.233 |
| 3M | 18.00 | 2026-07-06 | -39.39% | 0.786 |
| 6M | 9.38 | 2026-04-06 | +16.31% | 1.128 |
| 1Y | 27.38 | 2025-10-03 | -60.15% | 1.797 |
| 2Y | 11.21 | 2024-10-04 | -2.68% | — |
| 5Y | 17.00 | 2021-10-04 | -35.82% | 1.820 |
ClearPoint Neuro, Inc. Common Stock (NASDAQ:CLPT) stock price today is $10.91, and today's volume is 833,321. CLPT is down 4.716% today. The 30 day average volume is 692,823. CLPT market cap is $332.80M with 30.50M shares outstanding.